CD62L Is a Functional and Phenotypic Marker for Circulating Innate Lymphoid Cell Precursors

Area of Science:

• Immunology
• Cell Biology
• Inflammation Research

Background:

• Innate lymphoid cells (ILCs) are crucial for maintaining epithelial integrity during homeostasis.
• ILCs can act as potent immune effector cells during inflammatory conditions.
• Precursors to all ILC subsets (ILCP) have been identified in human peripheral blood (PB).

Purpose of the Study:

• To investigate the homing mechanisms of ILCP during homeostasis and inflammation.
• To determine the functional role of CD62L expression on ILCP.
• To explore the potential of CD62L as a diagnostic marker for inflammatory disorders.

Main Methods:

• Analysis of homing receptor expression (CD62L) on ILCP in mouse and human peripheral blood.
• Investigation of ILCP trafficking into mouse lymph nodes, assessing CD62L and S1P receptor dependence.
• Comparative analysis of CD62L expression on ILCP in healthy individuals versus Crohn disease patients.

Main Results:

• Homeostatic ILCP in mouse and human PB express CD62L, facilitating homing to secondary lymphoid organs.
• ILCP entry into lymph nodes is CD62L-dependent, and exit relies on S1P receptors.
• CD62L expression is reduced or absent on ILCP in Crohn disease patients, correlating with nonactivated states.

Conclusions:

• CD62L serves as a functional marker for nonactivated ILCP, regulating their homing to lymphoid tissues.
• The differential expression of CD62L on ILCP suggests its potential as a diagnostic biomarker in inflammatory diseases like Crohn disease.
• Understanding ILCP trafficking is critical for developing targeted immunotherapies for inflammatory disorders.